Article

A data-driven, sourced examination of Donald Trump's documented record across business, law, ethics, and governance — including six bankruptcies, four criminal indictments, 34 felony convictions, $7.8 trillion added to the national debt, and the catastrophic COVID-19 response.

A data-driven analysis using 30 years of Federal Reserve economic data comparing GDP growth, unemployment, and inflation across five presidential administrations — Clinton, Bush, Obama, Trump, and Biden.

Retrieval-Augmented Generation (RAG) is reshaping the legal industry — from contract review and due diligence to litigation research and compliance. Discover the 7 highest-impact RAG use cases for law firms, backed by real performance data and adoption statistics.

Financial regulators are watching AI outputs closely. RAG's source-cited, auditable architecture is emerging as the only AI approach that satisfies explainability and audit trail requirements from the FCA, SEC, and FINRA — while delivering real business value.

A data-driven analysis of how tariffs, ICE enforcement, and the Iran war are eroding America's economic momentum — backed by 11 FRED data layers, Wall Street forecasts, and bankruptcy filings showing the highest consumer financial stress since the Great Recession.

The global RAG market is projected to reach $3.33 billion in 2026, growing at 42.7% CAGR. Discover why Retrieval-Augmented Generation is the biggest AI opportunity for US businesses — and how Anablock Echo brings RAG to your business today.

Anablock built its own CRM platform — the Anablock CRM Assistant — on top of Anthropic's Claude models. This is the story of how we did it, what we learned, and why Claude was the right choice for a production-grade enterprise AI application.

The AI CRM and chatbot markets are exploding — but most tools are just legacy software with AI bolted on. Here's why Anablock's AI-native approach with Ana and Echo is built to win in 2026 and beyond.

The global Healthcare AI market is projected to grow from $39B in 2025 to nearly $200B by 2031 at a 38.6% CAGR. This deep-dive analysis breaks down the 7 highest-growth segments — from Clinical Generative AI to Drug Discovery — and presents a full TAM/SAM/SOM model for the US and EU enterprise market.

Never used Claude before? Here's everything you need to know to get up and running fast — from setting up Projects and connecting your tools, to running a full competitive analysis in under 10 minutes.